Overall decline in revenue and profit
First written in FY2017-Q1. 15 of 37 entries say "Restated". Latest entry: FY2027-H1.
- FY2027-H1Higher revenue and profit driven by revenue growth across all businessesAnnual report
「The Group achieved higher revenue across all businesses, resulting in higher revenue and profit overall.」
All 3 businesses recorded higher revenue in the interim period. Consolidated revenue was ¥14,284 million, up 4.9% from the previous interim period, and operating profit was ¥2,150 million, up 8.3%. - FY2026AdvancedAnnual report
「Against this backdrop, the Group's revenue, operating profit, ordinary profit, and profit attributable to owners of the parent all reached record highs, as sales were strong across all businesses.」
In FY2026, strong sales across all businesses drove revenue of ¥28,501 million, operating profit of ¥4,361 million, ordinary profit of ¥4,443 million, and profit attributable to owners of the parent of ¥3,345 million, all reaching record highs. - 2026-05-25AdvancedGeneral Meetings of Shareholders
「当社グループの業績につきましては全ての事業において販売が好調であったことから、売上高・営業利益・経常利益・親会社株主に帰属する当期純利益は、いずれも過去最高を更新いたしました。」
FY2026通期は売上高285億195万円、営業利益43億6,196万円、経常利益44億4,365万円、親会社株主に帰属する当期純利益33億4,563万円となり、主要指標の過去最高更新が続いた。 - FY2026-H1AdvancedAnnual report
「Strong sales in the particle measuring instruments and environmental equipment businesses resulted in higher revenue and profit than in the first half of the previous consolidated fiscal year.」
In FY2026-H1, revenue was ¥13,621 million, up 4.5% from the previous interim period, and operating profit was ¥1,984 million, up 12.7%, with overall revenue and profit continuing to increase. - FY2025AdvancedAnnual report
「Particularly strong sales in the particle measuring instruments business drove revenue, operating profit, ordinary profit, and profit attributable to owners of the parent to record highs.」
In FY2025, revenue was ¥27,877 million, operating profit was ¥4,033 million, ordinary profit was ¥4,106 million, and profit attributable to owners of the parent was ¥2,859 million, with all key metrics reaching record highs. - FY2025-H1AdvancedAnnual report
「Although sales in the medical equipment business declined, strong sales in the particle measuring instruments business drove revenue, operating profit, and ordinary profit to record highs.」
For the interim period, revenue was ¥13,040 million, operating profit was ¥1,761 million, and ordinary profit was ¥1,802 million, all reaching record highs. Profit attributable to owners of the parent was ¥1,197 million and declined due to higher costs for rebuilding the welfare building. - FY2024AdvancedAnnual report
「Strong sales in the particle measuring instruments and medical equipment businesses, together with the contribution from Norsonic AS, acquired by the environmental equipment business in November 2022, drove revenue, operating profit, ordinary profit, and profit attributable to owners of the parent to record highs.」
In FY2024, revenue was ¥25,726 million, operating profit was ¥3,474 million, ordinary profit was ¥3,562 million, and profit attributable to owners of the parent was ¥2,652 million, with all key metrics reaching record highs. - FY2024-Q3AdvancedAnnual report
「Against this backdrop, the Group's revenue and profit increased from the same quarter of the previous year, supported by strong sales in the medical equipment and particle measuring instruments businesses and the contribution from Norsonic AS, acquired by the environmental equipment business in November 2022.」
Revenue increased 9.0% year on year, operating profit increased 34.7%, ordinary profit increased 29.9%, and profit attributable to owners of the parent increased 55.1%, with higher revenue and profit continuing. - FY2024-Q2RestatedAnnual report
「Strong sales in the medical equipment and particle measuring instruments businesses, together with the contribution from Norsonic AS, acquired by the environmental equipment business in November 2022, resulted in higher revenue and profit than in the same quarter of the previous year.」
For the six months ended the second quarter, revenue was ¥12,101 million, up 12.1% year on year, and operating profit was ¥1,694 million, up 61.1%, with overall revenue and profit continuing to increase. - FY2024-Q1AdvancedAnnual report
「Strong sales across all businesses—the medical equipment, environmental equipment, and particle measuring instruments businesses—resulted in higher revenue and profit than in the same quarter of the previous year.」
All 3 businesses posted strong sales. Revenue was ¥6,013 million, up 16.0% year on year, and operating profit was ¥933 million, up 118.5%. The first quarter advanced from lower profit despite higher revenue in the previous full fiscal year to higher revenue and profit. - FY2023Revenue reached a record high, while operating profit and ordinary profit declinedAnnual report
「Revenue reached a record high due to strong sales in the medical equipment and particle measuring instruments businesses and the expansion of the environmental equipment business following the acquisition of Norsonic AS, a Norwegian manufacturer and developer of acoustic measuring instruments. Despite higher component prices and increased period expenses in the environmental equipment business, operating profit and ordinary profit were both at their second-highest levels ever, following the previous consolidated fiscal year.」
Full-year revenue reached a record ¥23,868 million, while operating profit was ¥2,844 million, down 8.4% from the previous fiscal year, and ordinary profit was ¥3,007 million, down 6.4%. - FY2023-Q3RestatedAnnual report
「Revenue increased from the same quarter of the previous year due in part to strong sales of particle measuring instruments. Profit declined, however, due in part to higher component prices and increased period expenses in the environmental equipment business.」
Higher revenue but lower profit continued on a cumulative basis through the third quarter. Revenue increased 5.3% year on year, while operating profit declined 10.3%. - FY2023-Q2RestatedAnnual report
「Against this backdrop, the Group's revenue increased from the same quarter of the previous year, due in part to strong sales of particle measuring instruments. Profit declined, however, due in part to higher component prices and increased period expenses in the environmental equipment business.」
Higher revenue but lower profit continued year on year. Revenue increased 5.7% and operating profit declined 12.6%; higher component prices and increased period expenses in the environmental equipment business were cited as factors behind the decline in profit. - FY2023-Q1Shifted to higher revenue and lower profitAnnual report
「Although revenue declined in the environmental equipment business, the recovery in the medical equipment business and strong sales of particle measuring instruments resulted in higher revenue than in the same quarter of the previous year. Profit declined, however, due in part to higher period expenses in the environmental equipment business.」
Revenue increased 6.4% year on year to ¥5,183 million, while operating profit declined 17.3% and ordinary profit declined 12.6%, shifting from higher revenue and profit in the previous fiscal year to higher revenue but lower profit. - FY2022-Q3RestatedAnnual report
「Strong sales of particle measuring instruments, together with a gradual recovery in sales in the medical equipment and environmental equipment businesses, resulted in higher revenue and profit than in the same quarter of the previous year.」
Higher revenue and profit continued on a cumulative basis through the third quarter. Revenue increased 9.4% year on year, operating profit increased 43.9%, and ordinary profit increased 44.8%. - FY2022-Q2RestatedAnnual report
「Strong sales of particle measuring instruments, together with a gradual recovery in sales in the medical equipment and environmental equipment businesses, resulted in higher revenue and profit than in the same quarter of the previous year.」
Higher revenue and profit continued on a cumulative basis through the second quarter. Revenue increased 9.5% year on year and operating profit increased 42.3%. - FY2022-Q1AdvancedAnnual report
「Strong sales of particle measuring instruments, together with a recovery in sales in the medical equipment and environmental equipment businesses, resulted in higher revenue and profit than in the same quarter of the previous year.」
The results shifted from lower revenue and profit in FY2021-Q1 to higher revenue and profit. Revenue increased 21.8% year on year and operating profit increased 97.3%, with all 3 businesses recording higher revenue. - FY2021RestatedAnnual report
「Although overall revenue and profit declined due to sluggish sales in the medical equipment and environmental equipment businesses, the decline in performance was contained to a certain extent by strong sales in the particle measuring instruments business.」
In FY2021, revenue and profit declined overall due to lower revenue and profit in the medical equipment and environmental equipment businesses. Revenue was ¥20,466 million, down ¥999 million from the previous fiscal year, and operating profit was ¥2,220 million, down ¥264 million. - FY2021-Q3RestatedAnnual report
「Although sales of particle measuring instruments remained strong, sales in the medical equipment and environmental equipment businesses declined from the same quarter of the previous year, resulting in lower revenue and profit overall.」
Lower revenue in the medical equipment and environmental equipment businesses offset strong performance in the particle measuring instruments business, and lower revenue and profit continued overall, with revenue down 5.0% and operating profit down 17.1%. - FY2021-Q2RestatedAnnual report
「Although sales of particle measuring instruments remained strong, sales in the medical equipment and environmental equipment businesses declined from the same quarter of the previous year, resulting in lower revenue and profit overall.」
Through the second-quarter cumulative period, strong performance in the particle measuring instruments business was offset by lower revenue in the medical equipment and environmental equipment businesses, resulting in lower revenue and profit overall. Revenue declined 11.1% year on year and operating profit declined 39.6%. - FY2021-Q1Shift from revenue growth and earnings decline to declines in bothAnnual report
「Although sales of particle measuring instruments remained strong, sales in the medical equipment and environmental equipment businesses declined from the same quarter of the previous year, resulting in lower revenue and profit overall.」
Compared with revenue of ¥4,888 million and operating profit of ¥627 million in the same period of the previous year, revenue was ¥3,997 million and operating profit was ¥261 million in the current quarter. Revenue declined 18.2% and operating profit declined 58.3%. - FY2020Shifted to higher revenue and lower profitAnnual report
「Revenue increased from the previous consolidated fiscal year due to strong sales in the medical equipment business. Profit declined overall, however, as the proportion of sales from lower-margin products increased and personnel expenses rose compared with the previous consolidated fiscal year.」
Revenue increased by ¥175 million from the previous fiscal year to ¥21,465 million, while operating profit declined by ¥217 million to ¥2,485 million, shifting from higher revenue and profit in the previous fiscal year to higher revenue but lower profit. - FY2020-Q3Revenue increased, while overall profit returned to approximately the previous year's levelAnnual report
「Revenue increased from the same quarter of the previous year due to strong sales in the medical equipment business. Profit, however, was broadly unchanged overall, as the environmental equipment and particle measuring instruments businesses recorded lower revenue and profit.」
Revenue increased 1.0% year on year, while operating profit declined 0.7%, ordinary profit declined 1.2%, and profit attributable to owners of the parent declined 3.1%. The results shifted from higher revenue and profit in the previous quarter to higher revenue with profit broadly unchanged from the previous year. - FY2020-Q2Higher revenue and profit maintained, but contributions by business changedAnnual report
「The Group's results increased in both revenue and profit from the same quarter of the previous year, supported by strong sales in the medical equipment business.」
Revenue increased 5.9% year on year and operating profit increased 32.4%. The medical equipment business achieved higher revenue and profit, while revenue in the environmental equipment business was broadly flat and the particle measuring instruments business recorded lower revenue and profit, changing the business mix from the previous quarter's growth in revenue and profit across all businesses. - FY2020-Q1AdvancedAnnual report
「Against this backdrop, the Group's results increased in both revenue and profit from the same quarter of the previous year across all businesses.」
While performance had previously varied by business, all three businesses—medical equipment, environmental equipment, and particle measuring instruments—achieved higher revenue and profit in the first quarter. Revenue increased 4.6% year on year, and operating profit increased 26.7%. - FY2019Higher revenue and profit, with key metrics reaching record highsAnnual report
「Strong sales in both the medical equipment and environmental equipment businesses drove revenue, operating profit, ordinary profit, and profit attributable to owners of the parent to record highs.」
Revenue was ¥21,289 million, operating profit was ¥2,703 million, ordinary profit was ¥2,789 million, and profit attributable to owners of the parent was ¥2,002 million, with all key metrics reaching record highs. - FY2019-Q3RestatedAnnual report
「The Group's results benefited from strong sales in both the medical equipment and environmental equipment businesses, resulting in higher revenue and profit than in the same quarter of the previous year.」
Both the medical equipment and environmental equipment businesses performed strongly, and overall revenue and profit continued to increase. Revenue increased 4.6% year on year, operating profit increased 2.0%, and ordinary profit increased 1.6%. - FY2019-Q2RestatedAnnual report
「Strong sales in both the medical equipment and environmental equipment businesses resulted in higher revenue and profit than in the same quarter of the previous year.」
Overall revenue and profit continued to increase on a cumulative basis through the second quarter. Revenue increased 4.4% year on year, operating profit increased 5.7%, ordinary profit increased 5.4%, and profit attributable to owners of the parent increased 6.4%. - FY2019-Q1RestatedAnnual report
「Strong sales in both the medical equipment and environmental equipment businesses resulted in higher revenue and profit than in the same quarter of the previous year.」
Both the medical equipment and environmental equipment businesses performed strongly, and overall revenue and profit continued to increase. - FY2018Higher revenue and profit, setting a new record highAnnual report
「Strong sales in the environmental equipment business resulted in higher revenue and profit than in the previous consolidated fiscal year. Revenue, operating profit, ordinary profit, and profit attributable to owners of the parent all reached record highs.」
Revenue was ¥20,350 million, operating profit was ¥2,572 million, ordinary profit was ¥2,651 million, and profit attributable to owners of the parent was ¥1,887 million, all reaching record highs. - FY2018-Q3RestatedAnnual report
「Overall revenue and profit increased from the same quarter of the previous year, as sales in the medical equipment business returned to growth and sales in the environmental equipment business remained strong.」
Overall revenue and profit continued to increase, following the previous quarter. Revenue increased 6.1% year on year, operating profit increased 61.8%, and ordinary profit increased 60.3%. - FY2018-Q2RestatedAnnual report
「Overall revenue and profit increased from the same quarter of the previous year, as strong sales in the environmental equipment business offset sluggish sales in the medical equipment business.」
Although the medical equipment business remained sluggish, the environmental equipment business offset this weakness, and overall revenue and profit continued to increase. - FY2018-Q1Returned to higher revenue and profitAnnual report
「Against this backdrop, the Group's results benefited from strong sales in the environmental equipment business, despite sluggish sales in the medical equipment business, resulting in higher revenue and profit overall than in the same quarter of the previous year.」
The first quarter shifted from higher revenue but lower profit in the previous full fiscal year to higher revenue and profit. Revenue increased 6.9% year on year, while operating profit increased 139.2%. - FY2017RestatedAnnual report
「Overall revenue increased, supported by strong sales of particle measuring instruments and hearing-aid revenue exceeding that of the previous consolidated fiscal year. Profit declined, however, due in part to higher selling expenses associated with promotional activities for hearing aids.」
For the full year, revenue was ¥19,194 million, up 1.8% from the previous fiscal year, while operating profit declined 17.7% and ordinary profit declined 17.4%, confirming higher revenue but lower profit. - FY2017-Q3RestatedAnnual report
「Against this backdrop, the Group's results benefited from strong sales of particle measuring instruments, as well as revenue from hearing aids and medical testing equipment exceeding that of the same quarter of the previous year, resulting in overall revenue growth. Profit declined, however, due to higher selling expenses associated with promotional activities for hearing aids.」
Revenue and profit continued to increase and decrease, respectively, on a cumulative basis through the third quarter. Revenue increased 1.1% year on year, while operating profit declined 22.6%. - FY2017-Q2Shift from lower revenue and lower earnings to higher revenue and lower earningsAnnual report
「Although revenue declined in the first quarter of the consolidated fiscal period, hearing-aid revenue recovered in the second quarter, while sales of medical testing equipment and particle measuring instruments remained strong. As a result, revenue for the six months ended the second quarter increased slightly from the same period of the previous year. Profit declined, however, due to higher selling expenses associated with promotional activities for hearing aids.」
Cumulative revenue turned to a 0.5% year-on-year increase, while operating profit declined 27.4% and ordinary profit declined 27.6%, changing the earnings profile from lower revenue and profit to higher revenue but lower profit. - FY2017-Q1First statedAnnual report
「Overall, revenue and profit declined from the same quarter of the previous year.」
Revenue declined 3.2% year on year, operating profit declined 49.5%, ordinary profit declined 48.0%, and profit attributable to owners of the parent declined 40.0%.